Canadian Institutes of Health Research (CIHR) – Project Grant: 2021-2026. Role: Co-Principal Investigator with Dr. Rick Ikesaka. Primary thromboprophylaxis with rivaroxaban in patients with malignancy and central venous catheters: TRIM-Line.

CIHR – Project Grant: Apr 2025-Mar 2028. Role: Principal Investigator. Development of a risk stratification score for recurrent venous thromboembolism and clinically relevant bleeding in patients with cancer-associated venous thromboembolism. CAN-CATCH Study.

CIHR – Project Grant: Apr 2025-Mar 2030. Role: Co-Principal Investigator with Dr. Joseph Shaw. Active cancer patients having cancer-related invasive procedures or surgery and needing perioperative management of anticoagulation therapy (ACE-HIGH): A prospective management cohort study.

CIHR – Project Grant: Oct 2023-Sep 2026. Role: Principal Investigator. Colchicine to quench the inflammatory response after deep vein thrombosis: A pilot randomized controlled trial - CONQUER-DVT Pilot Trial.

CIHR – Team Grant: Aug 1, 2024-Jul 31, 2025. Role: Co-Principal Investigator with Dr. Yan Xu. Inflammation, clonal hematopoiesis, and venous thromboembolism among ethnic and racially underrepresented older adults.

CIHR – Project Grant: 2019-2024. Role: Co-Principal Investigator. Co-Principal Investigator: Dr. Aurélien Delluc. Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism: a Randomized Controlled Trial using 18F-Fluorodeoxyglucose Positron Emission Computed Tomography. (SOME-2)